Guidelines

1. Eligibility & Registration

• Registration Requirement: Only registered delegates will be allowed to submit abstracts. Submission must be done exclusively via the official conference website only.
• Originality: Submissions must be original work not previously published or presented at National or International meetings.
  • Note: Presentations previously shared at Local or State levels are permitted but must be declared during submission.
• Limit per Author: A presenting author may submit a maximum of two oral presentations and two e-posters. Do not submit the same abstract under multiple categories.

2. Formatting & Technical Specifications

• Word Limit: Maximum 250 words.
• Language & Font: Must be in English using Times New Roman font.
• Title Rules: Use Sentence case (e.g., Clinical study of...). Keep it concise, avoid abbreviations in the title, and do not use all capital letters.
• Graphics:
  • Do not include tables, graphs, or references within the text.
  • Recommended: Submit a single JPG file of a “Graphic Abstract” via the designated upload option. (Graphic abstract is recommended but not compulsory)
• Style: Use numerals for numbers (unless starting a sentence). Use generic drug names only; avoid commercial/brand names.
• Declare conflict of interest, if any.

3. Structure & Content

Choose the appropriate structure based on your submission type:

• Original Research: 1) Background, 2) Aims & Objectives, 3) Materials & Methods, 4) Results, Limitations, & Conclusions. (Results must be included).
• Case Reports/Series: 1) Introduction, 2) Case Report/Series, 3) Discussion.
• Avoid Vague Statements: Do not use phrases like “the results will be discussed.” Be specific.

4. Ensuring Blinded Review

To maintain a fair review process:

• Do not include names of authors, collaborators, hospitals, colleges, or locations within the title or abstract body.
• Author affiliations must be entered separately in the online form fields provided.
• Award Papers: Stricter anonymity applies; ensure no mention of institutions or co-authors is present.

5. Important Deadlines & Policy

• Submission Deadline: 31st July 2026.
• Notification of Acceptance: 31th October 2026.
• Correspondence: The first author will be the primary contact. Please ensure your email and mobile number are accurate.
• Copyright: By submitting, authors transfer copyright to the Organizing Committee for publication in print or electronic media.
• Compliance: Non-adherence to these guidelines may result in automatic rejection.